Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Diagnostic and Management of malignant transformation of ovarian mature teratoma

Alpha Boubacar Conte, Jihad Jamor, Fatima Zohra Fdili Alaoui, Mohamed Yessoufou, Sofi Jayi, Hikmat Chaara, Moulay Abdelilah Melhouf.




Abstract
Cited by 0 Articles

Mature cystic teratomas (or more conventionally dermoid cysts) are the most frequent germ ovarian tumors (90 to 95% of cases) and represent 20 to 25% of organic ovarian tumors. It is almost always a benign lesion that can occur at any age, but most often in young women. Degeneration is seen only in less than 2% of cases, especially after menopause. It corresponds to the transformation of one of the elements of the dermoid cyst into a cancerous tissue of a non-germinal nature which can be either an epidermoid carcinoma, an adenocarcinoma, or exceptionally a sarcoma or a melanoma. The diagnosis of certainty is established by the anatomopathological study of the surgical part. The treatment of cancerous teratomas is surgical and analogous to that of malignant epithelial tumors of the ovary. We report an observation through which we carried out a review of the literature to specify the epidemiological, anatomopathological, clinical, radiological characteristics and the therapeutic management of cancerous teratomas of the ovary

Key words: Mature teratoma, Carcinoma teratoma, Ovarian cancer






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.